Tech Company Financing Transactions
Crescendo Bioscience Funding Round
Crescendo Bioscience, operating out of South San Francisco, received $15 million in funding from Kleiner Perkins Caufield & Byers and private investors.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
341 Oyster Point Blvd
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Not Recorded
Overview
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Hagstrom
Chief Information Officer
Alex Bangs
Chief Medical Officer
Oscar Segurado
Chief Operating Officer
Brian Bertha
VP - Bus. Development
Lucy Lu
VP - Finance
Timothy Henn
VP - Sales
Erik Harris
Browse more venture capital transactions:
Prev: 6/30/2008: Stemgent venture capital transaction
Next: 6/30/2008: Command Information venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs